Azithromycin: 4.5- Or 6.0-gram dose in the treatment of patients with chronic prostatitis caused by Chlamydia trachomatis - A randomized study [1]

Journal of Chemotherapy

Volumn 16, Issue 4, 2004, Pages 408-410

  Škerk, Višnja ^a   Krhen, I ^b   Lisic M ^a   Begovac, J ^a   Cajic V ^a   Zekan, S ^a   Škerk, Vedrana ^c   Sternak, S L ^d   Topic A ^a   Schonwald S ^a  

^a Croatia   (Croatia)

^b KBC Zagreb   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

^d CROATIAN NATIONAL INSTITUTE OF PUBLIC HEALTH   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; AZITHROMYCIN; CLARITHROMYCIN; DOXYCYCLINE;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; BACTERIUM EXAMINATION; BLOOD EXAMINATION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CHRONIC PROSTATITIS; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ELIMINATION; DRUG SENSITIVITY; DRUG TOLERABILITY; ERADICATION THERAPY; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PERSISTENT INFECTION; RANDOMIZED CONTROLLED TRIAL; REMISSION; SERUM BACTERICIDAL ACTIVITY; SYMPTOM; TREATMENT FAILURE; TRICHOMONAS VAGINALIS; TRICHOMONIASIS;

EID: 3943050625     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2004.16.4.408     Document Type: Letter

References (6)

1. European Association of Urology. Guidelines on urinary and male genital tract infections. Drukkerij Gelderland bV, Arnhem, The Netherlands, 2002: 49-56.
2. Weidner W, Diemer Th, Huwe P, Rainer M, Ludwig M. The role of Chlamydia trachomatis in prostatitis. Int J Antimicrob Agents 2002; 19: 466-70.
3. Škerk V, Schönwald S, Krhen I, et al. Etiology of chronic prostatitis. Int J Antimicrob Agents 2002; 19: 471-4.
4. Škerk V, Schönwald S, Krhen I, et al. Comparative analysis of azithromycin and clarithromycin efficacy and tolerability in the treatment of chronic prostatitis caused by Chlamydia trachomatis. J Chemother 2002; 14: 384-9.
5. Škerk V, Schönwald S, Krhen I, et al. Comparative analysis of azithromycin and ciprofloxacin in the treatment of chronic prostatitis caused by Chlamydia trachomatis. Int J Antimicrob Agents 2003; 21: 457-462.
6. Škerk V, Krhen I, Lisić M. et al. Comparative randomized pilot study of azithromycin and doxycycyline efficacy and tolerability in the treatment of prostate infection caused by Chlamydia trachomatis. Int J Antimicrob Agents 2004; in press.